A comprehensive, data-driven approach to new indications discovery
NuMedii leverages vast amounts of molecular data to systematically and rapidly identify new and potentially efficacious indications for existing drugs. Our New Indications Discovery technology is based on a validated technology developed at Stanford University. By focusing on new indications with the highest probability for demonstrating efficacy, the cost, time and risk for developing new therapies are significantly reduced. New indications identified through the use of NuMedii’s technology will fill a critical need in drying Pharma and limited biotech pipelines.
Learn more about NuMedii’s New Indications Discovery Technology>>
Innovative Technology
NuMedii’s New Indications Discovery technology uses proprietary and proven integrative biology methods to identify new indications.
Learn moreNew Opportunities
Put the power of the New Indications Discovery technology to work for your drug. NuMedii is seeking partnerships across many therapeutic categories.
Learn moreTeam
NuMedii is backed by a team comprised of world renowned scientists and biotechnology entrepreneurs.
Learn more